Today: 11 June 2026
Browse Category

Mergers and Acquisitions 24 October 2025 - 26 November 2025

Spectris (LON: SXS) Share Price Today, 26 November 2025 – Fresh Stake Disclosures as KKR’s £41.75 Takeover Nears the Finish Line

Spectris (LON: SXS) Share Price Today, 26 November 2025 – Fresh Stake Disclosures as KKR’s £41.75 Takeover Nears the Finish Line

Spectris shares traded around 4,132p–4,134p in London on Monday, less than 1% below the £41.75 per share takeover offer from KKR-backed Project Aurora Bidco. Trading was subdued, with activity focused on disclosure filings including a major holdings notice from JPMorgan Chase, which lifted its economic interest above 8%. No new terms or surprises emerged.
26 November 2025
··
Amphenol Stock Today (APH): Price, Institutional Moves and M&A Outlook on November 26, 2025

Amphenol Stock Today (APH): Price, Institutional Moves and M&A Outlook on November 26, 2025

Amphenol closed Tuesday at $137.81, near its all-time high, after nearly tripling from its 52-week low and gaining about 90% in the past year. Institutional investors now hold roughly 97% of shares, with recent 13F filings showing both new buying and some profit-taking. Market capitalization stands near $169 billion. Trading volume Tuesday was about 7 million shares, below the recent average.
26 November 2025
··
Exact Sciences (EXAS) Stock Today: Analyst Downgrades, Abbott’s $21 Billion Takeover and Legal Scrutiny – 25 November 2025

Exact Sciences (EXAS) Stock Today: Analyst Downgrades, Abbott’s $21 Billion Takeover and Legal Scrutiny – 25 November 2025

Exact Sciences shares traded near $101 on Nov. 25, just below their all-time high, after Abbott’s $21 billion takeover offer at $105 per share. The stock surged 45% in a week, with Wall Street downgrading to “Hold” as merger-arb funds entered. Closing is expected in Q2 2026, pending approvals. Shareholder lawyers have begun reviewing the deal.
25 November 2025
··
Exact Sciences (EXAS) Stock Today, November 24, 2025: Abbott Buyout Spread, Analyst Downgrades and UBS Target Hike

Exact Sciences (EXAS) Stock Today, November 24, 2025: Abbott Buyout Spread, Analyst Downgrades and UBS Target Hike

Exact Sciences shares traded near $101, just below Abbott’s $105-per-share cash offer, as analysts adjusted ratings and a law firm launched a fairness probe into the deal. The stock hovered near its 52-week high, up almost 80% year-to-date. UBS and Jefferies set new $105 targets, while Benchmark and Leerink downgraded the stock. Market cap stood at about $19.1 billion.
24 November 2025
··
BHP Group Ltd (ASX:BHP) Today: Share Price Moves, Anglo American Deal Collapse and China Iron Ore Dispute – 24 November 2025

BHP Group Ltd (ASX:BHP) Today: Share Price Moves, Anglo American Deal Collapse and China Iron Ore Dispute – 24 November 2025

BHP Group ended Monday at A$40.62, up 0.6%, trailing the S&P/ASX 200’s 1.3% gain. The company confirmed it has dropped renewed takeover talks with Anglo American, triggering a six-month pause under UK rules. Anglo shares rose about 2% in London as investors shifted focus to the pending Anglo-Teck merger. Major BHP shareholders are urging management to prioritize project delivery over new deals.
24 November 2025
·····
Warner Bros Discovery Stock Skyrockets on $60B Takeover Rumors

Warner Bros. Discovery Bidding War: Paramount, Comcast and Netflix Submit First-Round Offers – All the Warner Bros. News on November 21, 2025

Warner Bros. Discovery has received first-round buyout bids from Paramount Skydance, Comcast, and Netflix, sources say. Paramount seeks to acquire the entire company, while Comcast and Netflix are bidding for the studio and streaming assets only. The board will review offers before Thanksgiving. No sale is guaranteed.
21 November 2025
····
Euronext Paris Shocks Markets with Historic Roots, Surging Stocks & Bold 2025 Moves

Euronext Today, 18 November 2025: European Stocks Slide as Eutelsat’s €828m Capital Raise, Nexans Buyback and AkzoNobel–Axalta Mega‑Merger Dominate Trade

The Euronext 100 index fell about 1.3% to 1,689–1,690 points by late morning, with the CAC 40 and AEX also down over 1%. Euronext N.V. launched its €250 million share buyback program today, set to run through March 2026. Broader European markets tracked similar declines amid concerns over tech valuations and fewer expected Fed rate cuts.
18 November 2025
·····
Yum Brands’ Pizza Hut Shake‑Up: Why Wall Street Is Turning Bullish as Convenience Stores Circle the Deal – 18 November 2025

Yum Brands’ Pizza Hut Shake‑Up: Why Wall Street Is Turning Bullish as Convenience Stores Circle the Deal – 18 November 2025

Yum! Brands has launched a formal review of Pizza Hut, considering a possible sale as the chain’s U.S. same-store sales fell 6% in Q3 2025. Pizza Hut now accounts for just 11% of Yum’s operating profit, while Taco Bell and KFC drive growth. Goldman Sachs and Barclays are advising. No deadline or outcome has been set.
18 November 2025
··
Ondas Holdings (ONDS) Lands $8.2M Airport Drone Defense Deal and Closes $225M Sentrycs Acquisition on November 17, 2025

Ondas Holdings (ONDS) Lands $8.2M Airport Drone Defense Deal and Closes $225M Sentrycs Acquisition on November 17, 2025

Ondas Holdings secured an $8.2 million contract to deploy counter-drone systems at a major European airport and closed its $225 million acquisition of Israel-based Sentrycs. The company reported record Q3 revenue of $10.1 million, up more than sixfold year-over-year. ONDS shares traded around $7.00 midday, down 2.5% after recent gains. Analyst price targets rose, with Oppenheimer upgrading the stock to “outperform.”
17 November 2025
··
Galecto (GLTO) Soars on Damora Therapeutics Acquisition and $285M Financing: IND in 2026, Proof‑of‑Concept in 2027

Galecto (GLTO) Soars on Damora Therapeutics Acquisition and $285M Financing: IND in 2026, Proof‑of‑Concept in 2027

Galecto said it acquired Damora Therapeutics and raised $284.9 million in an oversubscribed private placement, extending its cash runway into 2029. The moves shift Galecto’s focus to mutant calreticulin therapies for myeloproliferative neoplasms. GLTO shares surged about 285% in pre-market trading. No shareholder vote was required for the acquisition.
10 November 2025
··
Bubble or Boom? Magnificent Seven Stocks Face Critical Earnings Showdown

Alphabet (GOOGL) Stock Today, Nov 7, 2025: Shares Slip ~2.6% as YouTube TV–Disney Blackout Persists; DOJ Clears $32B Wiz Deal

Alphabet Class A shares fell 2.6% to $277.45 midday Friday, tracking a broader tech decline as U.S. stocks headed for a losing week. The DOJ cleared Alphabet’s $32 billion acquisition of cloud-security firm Wiz, with closing expected in 2026 pending further approvals. Disney and YouTube TV remain in talks to restore ABC and ESPN after a blackout last week. Alphabet completed $17.5 billion in USD and €6.5 billion in euro bond offerings on Nov. 6.
7 November 2025
···
Marvell Technology Soars After Report SoftBank Explored Takeover, Eyeing ARM Tie‑Up — Nov. 6, 2025

Marvell Technology Soars After Report SoftBank Explored Takeover, Eyeing ARM Tie‑Up — Nov. 6, 2025

Marvell Technology shares rose as much as 10% Thursday after Bloomberg reported SoftBank explored acquiring the U.S. chipmaker earlier this year. No deal was reached and talks are not active, but sources said interest could return. The proposed tie-up would have combined Marvell with ARM, making it the largest semiconductor deal on record. Marvell shares remained up about 6% intraday.
6 November 2025
··
Schwab to Acquire Forge Global in $660 Million All‑Cash Deal, Accelerating the Race to Retail Access for Private Shares (Nov. 6, 2025)

Schwab to Acquire Forge Global in $660 Million All‑Cash Deal, Accelerating the Race to Retail Access for Private Shares (Nov. 6, 2025)

Charles Schwab will acquire Forge Global for $660 million in cash, or $45 per share, a 72% premium to Forge’s last close. Both boards approved the deal, with closing expected in the first half of 2026 pending regulatory and shareholder approvals. Forge’s top shareholders, Motive Capital and Deutsche Börse, have agreed to support the transaction. Forge shares surged in premarket trading after the announcement.
6 November 2025
···
Luminar (LAZR) Stock Surges on Lidar Hype – Volvo & NVIDIA Deals Ignite Investor Interest

Luminar’s LIDAR Rollercoaster: Stock Rockets on Buyout Buzz, Then Plunges Amid Cash Crunch

Luminar shares plunged up to 45% on Oct. 31 after the company warned of a cash crunch and announced a 25% workforce cut. The firm reported $429 million in debt and just $74 million in cash, and may run out of funds by Q1 2026. Founder Austin Russell has proposed a buyout, but no deal is assured. CFO Thomas Fennimore will resign Nov. 13 amid ongoing financial turmoil.
1 November 2025
··
Paramount Slashes 1,000 Jobs as New CEO Eyes $60 B Warner Bros. Takeover

Paramount Slashes 1,000 Jobs as New CEO Eyes $60 B Warner Bros. Takeover

Paramount Skydance began laying off about 1,000 employees this week, roughly 5% of its workforce, following its $8.4 billion merger with Skydance Media. Nearly 100 CBS News staffers are affected. CEO David Ellison said the cuts are necessary for long-term stability. Paramount has made multiple failed takeover bids for Warner Bros. Discovery, whose stock surged nearly 10% on the news.
29 October 2025
··
Skyworks Soars 18% on $22B Qorvo Merger – What’s Next for the Chipmaker?

Skyworks Soars 18% on $22B Qorvo Merger – What’s Next for the Chipmaker?

Skyworks shares jumped nearly 18% to around $89 on Oct. 28 after announcing a $22 billion cash-and-stock deal to acquire Qorvo. Qorvo holders will receive $32.50 and 0.96 Skyworks shares per Qorvo share. Skyworks recently reported Q3 revenue of $965 million and non-GAAP EPS of $1.33, both above forecasts. Wall Street remains cautious, with an average 12-month target of $70.90.
28 October 2025
···
Adverum (ADVM) Stock Skyrockets on News of Lilly’s $12.47/Share Gene Therapy Deal

Adverum (ADVM) Stock Skyrockets on News of Lilly’s $12.47/Share Gene Therapy Deal

Eli Lilly said Oct. 24 it will buy Adverum Biotechnologies for $3.56 per share plus a CVR worth up to $8.91, targeting Adverum’s lead gene therapy Ixo-vec for wet AMD. Adverum shares jumped 17% on the news but stayed well below the $12.47 maximum deal value. The agreement includes a $65 million secured loan to fund trials before closing. Adverum had warned its cash would run out by Q4 2025.
24 October 2025
···
1 … 4 5 6 7

Stock Market Today

  • Is Disney (DIS) Undervalued After Recent Share Price Decline?
    June 10, 2026, 7:13 PM EDT. Walt Disney's (DIS) share price recently closed at $98.61, down 0.8% over the past week and 16.6% over the last year, reflecting market reassessment amid ongoing business restructuring in streaming, parks, and content. A Discounted Cash Flow (DCF) analysis estimates Disney's intrinsic value at $111.53 per share, suggesting the stock is undervalued by approximately 11.6%. Disney's free cash flow is projected to grow from $8.53 billion to $14.15 billion by 2030. Despite recent price weakness, Simply Wall St assigns a valuation score of 5 out of 6, indicating potential value. Investors should weigh these projections against market risks and potential rewards as Disney continues its strategic transformation.

Latest articles

Social Security 2032 Cut Edges Closer With Trustees Warning of 22% Drop

Social Security 2032 Cut Edges Closer With Trustees Warning of 22% Drop

11 June 2026
Social Security’s retirement and survivor fund is now projected to run out in late 2032, a quarter earlier than last year, forcing a 22% cut in benefits unless Congress acts, as lower birth rates, reduced immigration, and 2025 tax law changes drive a faster depletion of reserves, according to trustees.
Navan Shares Rally, Pushing NAVN Close to IPO Mark on Upbeat Outlook

Navan Shares Rally, Pushing NAVN Close to IPO Mark on Upbeat Outlook

11 June 2026
Navan shares surged over 18% after hours as the company raised its fiscal 2027 revenue growth outlook to 30% from 24%, following a 40% revenue jump to $220.2 million and a 50% surge in gross booking volume to $3.1 billion, beating Wall Street estimates and fueled by strong enterprise travel demand and AI-driven tools.
Intel Drops as Chip Selloff Hits Shares Despite Google AI Bid Hopes

Intel Drops as Chip Selloff Hits Shares Despite Google AI Bid Hopes

11 June 2026
Intel shares fell 0.8% to $107.04 as the stock’s main catalyst—a reported Google order for over 3 million Intel-made TPUs for 2028—remains unconfirmed, while the Philadelphia Semiconductor Index plunged 3.6% and tech stocks entered correction territory, highlighting investor focus on external foundry demand amid sector-wide profit-taking and supply chain concerns.
Go toTop